Global University Venturing

Stanford-StartX Fund is set to exit the IoT security platform developer in a $75m purchase by Palo Alto Networks.

Emory Investment Management has added Adam Marchick as an investor, building on four hires to the investment team made last year.

Oilfield water management company Sourcewater secured series A funding from backers including Marubeni and Bison having launched from MIT’s Energy Ventures program in 2014.

University of Pennsylvania-allied CNS disease therapy developer Passage Bio lured contributions from investors including Lilly Asia Ventures, which also featured in its $116m series A earlier this year.

The telecommunications spectrum provider has now raised $120m altogether, SBA Communications and American Tower contributing to its latest round.

Cartica AI, an autonomous perception tech developer forged from Technion spinout Cortica, secured capital from OurCrowd, Continental, Toyota and BMW in what appears to be its first publicly-disclosed round.

MIT Media Lab spinout Ginger has raised $35m as it looks to further develop its mental and emotional health support app.

Osage University Partners has added IU Ventures to its lineup of academic partners in a deal enabling it to back IU Ventures clients as a co-investor.

Gyroscope Therapeutics, a dry AMD treatment developer exploiting University of Cambridge research, has secured $61.2m from cornerstone investors Cambridge Innovation Capital and Syncona.

Leveraging University of Glasgow and University of Southern Denmark research, Caldan is targeting a free fatty acid receptor associated with fatty liver disease and type 2 diabetes.

Novartis, Medtronic and SinoPharm will exit the stem cell-based diabetes therapy developer in an acquisition by Vertex Pharmaceuticals.